SU-302
N/A
Report date: 2025/06/11 20:01:15
NME
Base Information
Drug NameSU-302
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMax-Planck-Gesellschaft zur Förderung der Wissenschaften eV
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSugen LlcMax-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A